Slater H, Goldfarb I W, Jacob H E, Hill J B, Srodes C H
Cancer. 1985 Oct 15;56(8):2074-7. doi: 10.1002/1097-0142(19851015)56:8<2074::aid-cncr2820560831>3.0.co;2-f.
One hundred forty consecutive cancer patients had percutaneously placed subclavian vein catheters for up to 882 days' duration. The incidence of suspected and proven catheter-related sepsis was low. This is a cost-effective alternative to tunneled catheter insertion for chronic venous access in cancer patients.
140例连续的癌症患者经皮置入锁骨下静脉导管，置管时间长达882天。疑似和确诊的导管相关脓毒症发生率较低。对于癌症患者的慢性静脉通路，这是一种比置入隧道式导管更具成本效益的替代方法。
